Vivos Therapeutics (VVOS) Stock News
$VVOS · NASDAQ · 1 stories in 30 daysBORSA has published 1 story on Vivos Therapeutics (VVOS) in the past 30 days. BORSA’s news read on VVOS is bullish at 61/100, based on 1 company event over the past 7 days. Vivos Therapeutics’ next earnings report is scheduled for Wednesday, Nov 18.
The wire on $VVOS
newest first · updated · direct subject stories onlyVivos Therapeutics received confirmation from Nasdaq regarding compliance with the shareholders' equity standard.
bullish 65 · impact 30The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.
Vivos Therapeutics (VVOS) stock: common questions
Is the news on VVOS bullish or bearish?
BORSA’s news read on VVOS is bullish at 61/100, based on 1 company event over the past 7 days. It measures the news only: it is separate from price action and is not investment advice.
When does Vivos Therapeutics report earnings?
Vivos Therapeutics’ next earnings report is scheduled for Wednesday, Nov 18.